The Latest in IT Security

Proteus picks UK for ‘smart pill’ production and testing

10
Mar
2014

Privately held Proteus Digital Health, which is working with drugmakers including Novartis and Otsuka, said on Monday the new site would employ some 200 skilled staff and serve as a hub for the emerging digital medicine industry. The move was welcomed by Prime Minister David Cameron, who said it showed Britain’s ability to attract high-tech companies. Proteus already has European and U.S. approval for its “smart pill” technology system, in which a tiny sensor is embedded in a tablet and linked to a patch worn on the patient’s abdomen. Several teams within Britain’s state-run National Health Service plan to test the benefits of using the sensor technology in various fields, including in treating hypertension, or high blood pressure.

Comments are closed.

Categories

SATURDAY, AUGUST 19, 2017

Featured

Archives

Latest Comments

Social Networks